Showing results (301-310 of 426) with videos related to
Sort By:
Pageof 43
Science Translational Medicine|August 9, 2019
Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancerBradon R McDonald, Tania Contente-Cuomo, Stephen-John Sammut, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 30, 2023
Combined loss of CDH1 and downstream regulatory sequences drive early-onset diffuse gastric cancer and increase penetrance of hereditary diffuse gastric cancerCelina São José, José Garcia-Pelaez, Marta Ferreira, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2026
PI3K inhibition in combination with tamoxifen in patients with metastatic HR+/HER2- breast cancer: clinical and circulating tumor DNA resultsRosie A B Voorthuis, Mafalda Oliveira, Annelot G J van Rossum, et al.Nature Genetics|February 2, 2020
Author Correction: ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment responseSankari Nagarajan, Shalini V Rao, Joseph Sutton, et al.British Journal of Cancer|March 16, 2021
PI3K activation promotes resistance to eribulin in HER2-negative breast cancerAlbert Gris-Oliver, Yasir H Ibrahim, Martín A Rivas, et al.NPJ Breast Cancer|July 19, 2024
Gene expression signature for predicting homologous recombination deficiency in triple-negative breast cancerJia-Wern Pan, Zi-Ching Tan, Pei-Sze Ng, et al.EMBO Molecular Medicine|May 10, 2023
Comparison of tumor-informed and tumor-naïve sequencing assays for ctDNA detection in breast cancerAngela Santonja, Wendy N Cooper, Matthew D Eldridge, et al.Nature|March 15, 2019
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroupsOscar M Rueda, Stephen-John Sammut, Jose A Seoane, et al.Science Translational Medicine|July 2, 2010
Genomic architecture characterizes tumor progression paths and fate in breast cancer patientsHege G Russnes, Hans Kristian Moen Vollan, Ole Christian Lingjærde, et al.EMBO Molecular Medicine|February 22, 2011
ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epitheliumDaniel G Holland, Angela Burleigh, Anna Git, et al.Pageof 43